[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 3 sources · 18 days · First seen · Last updated

Vuno medical AI international expansion

Overview

Medical AI company Vuno has expanded its international presence through academic engagement and market entry. In September 2026, the company scheduled the ‘Global Patient Safety Summit in Pediatrics’ in Seoul. This symposium brings together international and domestic experts to discuss AI-based Early Warning Systems (EWS) and Rapid Response Systems (RRS) specifically designed to detect clinical deterioration in pediatric patients.

Concurrently, Vuno announced its entry into the Chinese market via two strategic tracks. In Hainan Province, the company signed a two-year exclusive distribution agreement with Guorun for its cardiac arrest prediction device, VUNO Med®-DeepCARS, utilizing the Boao Lecheng International Medical Tourism Pilot Zone to facilitate early use before formal registration. Additionally, in Jiangsu Province, Vuno is collaborating with BioVision to integrate its VUNO Med-Fundus AI into a chronic disease management platform, targeting primary healthcare facilities to assist in detecting retinal abnormalities.

Entities

Vuno · Seoul National University Hospital · Guorun · University of Toronto · Boao Lecheng International Medical Tourism Pilot Zone

Timeline

  1. [BUSINESS] 2 sources
    VUNO enters Chinese market with medical AI distribution deals

    South Korean medical AI firm VUNO is entering the Chinese market via an exclusive deal for its cardiac arrest prediction device in Hainan and a platform integration for retinal imaging AI in Jiangsu.

  2. [TECHNOLOGY] 2 sources
    Vuno to host global symposium on pediatric patient safety and AI

    Medical AI firm Vuno will host a global symposium in Seoul on September 19 to discuss AI-based early warning systems and rapid response protocols for pediatric patient safety.

Sources

bokuennews.com · thebionews.net · zdnet.co.kr